Journal of Neural Transmission

, Volume 126, Issue 2, pp 173–182 | Cite as

Acute and chronic methylphenidate administration in intact and VTA-specific and nonspecific lesioned rats

  • Stephanie A. Ihezie
  • Ming M. Thomas
  • Nachum DafnyEmail author
Neurology and Preclinical Neurological Studies - Original Article


Methylphenidate (MPD) is a psychostimulant used for the treatment of ADHD and works by increasing the bioavailability of dopamine (DA) in the brain. As a major source of DA, the ventral tegmental area (VTA) served as the principal target in this study as we aimed to understand its role in modulating the acute and chronic MPD effect. Forty-eight male Sprague–Dawley rats were divided into control, sham, electrical lesion, and 6-OHDA lesion groups. Given the VTA’s implication in the locomotive circuit, three locomotor indices—horizontal activity, number of stereotypy, and total distance—were used to measure the animals’ behavioral response to the drug. Baseline recording was obtained on experimental day 1 (ED 1) followed by surgery on ED 2. After recovery, the behavioral recordings were resumed on ED 8. All groups received daily intraperitoneal injections of 2.5 mg/kg MPD for six days after which the animals received no treatment for 3 days. On ED 18, 2.5 mg/kg MPD was re-administered to assess for the chronic effect of the psychostimulant. Except for one index, there was an increase in locomotive activity in all experimental groups after surgery (in comparison to baseline activity), acute MPD exposure, induction with six daily doses, and after MPD re-challenge. Furthermore, the increase was greatest in the electrical VTA lesion group and lowest in the 6-OHDA VTA lesion group. In conclusion, the results of this study suggest that the VTA may not be the primary nucleus of MPD action, and the VTA plays an inhibitory role in the locomotive circuit.


Behavior Locomotion Ritalin CNS lesion Psychostimulant Sensitization 



The study was supported by NIH RO1 DA 02722 Grant.

Compliance with ethical standards

Conflict of interest

The authors declare no competing financial interests.


  1. Abbas Z, Sweet A, Hernandez G, Arvanitogiannis A (2017) Adolescent exposure to methylphenidate increases impulsive choice later in life. Front Behav Neurosci 11:214. Google Scholar
  2. Askenasy EP, Taber KH, Yang PB, Dafny N (2007) Methylphenidate (Ritalin): behavioral studies in the rat. Int J Neurosci 117:757–794Google Scholar
  3. Beier KT, Steinberg EE, DeLoach KE, Xie S, Miyamichi K, Schwarz L, Gao XJ, Kremer EJ, Malenka RC, Luo L (2015) Circuit architecture of VTA dopamine neurons revealed by systematic input-output mapping. Cell 162(3):622–634Google Scholar
  4. Bolanos CA, Barrot M, Berton O, Wallace-Black D, Nestler EJ (2003) Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 54:1317–1329. (03)00570-5Google Scholar
  5. Bonci A, Williams JT (1996) A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 16:631–639Google Scholar
  6. Carlezon WA, Mague SD, Andersen SL, Carlezon B (2003) Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 54:1330–1337. Google Scholar
  7. Challman TD, Lipsky JJ (2000) Methylphenidate: its pharmacology and uses. Mayo Clin Proc 75:711–721Google Scholar
  8. Charara A, Smith Y, Parent A (1996) Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry. J Comp Neurol 364(2):254–266Google Scholar
  9. Ciccarelli A, Calza A, Panzanelli P, Concas A, Giustetto M, Sassoè-Pognetto M (2012) Organization of GABAergic synaptic circuits in the rat ventral tegmental area. PloS One 7(10):e46250Google Scholar
  10. Clements JR, Toth DD, Highfield DA, Grant SJ (1991) Glutamate-like immunoreactivity is present within cholinergic neurons of the laterodorsal tegmental and pedunculopontine nuclei. Adv Exp Med Biol 295:127–142Google Scholar
  11. Clemow DB, Walker DJ (2014) The potential for misuse and abuse of medications in ADHD: a review. Postgrad Med 126(5):64–81Google Scholar
  12. Comoli E, Coizet V, Boyes J, Bolam JP, Canteras NS, Quirk RH, Overton PG, Redgrave P (2003) A direct projection from superior colliculus to substantia nigra for detecting salient visual events. Nat Neurosci 6(9):974–980Google Scholar
  13. Dommett E, Coizet V, Blaha CD, Martindale J, Lefebvre V, Walton N, Mayhew JE, Overton PG, Redgrave P (2005) How visual stimuli activate dopaminergic neurons at short latency. Science 307(5714):1476–1479Google Scholar
  14. Ferreira JGP, Del-Fava F, Hasue RH, Shammah-Lagnado SJ (2008) Organization of ventral tegmental area projections to the ventral tegmental area-nigral complex in the rat. Neuroscience 153:196–213Google Scholar
  15. French ED (1986) [Abstract] Effects of N-allylnormetazocine (SKF 10,047), phencyclidine, and other psychomotor stimulants in the rat following 6-hydroxydopaine lesion of the ventral tegmental area. Neuropharmacology 25(4):447–450Google Scholar
  16. Gaytan O, Al-Rahim S, Swann A, Dafny N (1997) Sensitization to locomotor effects of methylphenidate in rat. Life Sci 61:101–107Google Scholar
  17. Gaytan O, Yang P, Dafny N (2000) Diurnal differences in sensitization to methylphenidate. Brain Res 864:24–39Google Scholar
  18. Georges F, Aston-Jones G (2002) Activation of ventral tegmental area cells by the bed nucleus of the stria terminalis: a novel excitatory amino acid input to midbrain dopamine neurons. J Neurosci 22(12):5173–5187Google Scholar
  19. German DC, Manaye KF (1993) Midbrain dopaminergic neurons (nuclei A8, A9, and A10): three-dimensional reconstruction in the rat. J Comp Neurol 331(3):297–309Google Scholar
  20. Gnanalingham KK, Roberston RG (1994) The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat—an autoradiographic study. Brain Res 640:185–194Google Scholar
  21. Graham WC, Crossman AR, Woodruff GN (1990) Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat. Brain Res 514:93–102Google Scholar
  22. Hand TH, Franklin KB (1985) 6-OHDA lesions of the ventral tegmental area block morphine-induced but not amphetamine-induced facilitation of self-stimulation. Brain Res 328(2):233–241Google Scholar
  23. Harvey RC, Sen S, Deaciuc A, Dwoskin LP, Kantak KM (2011) Methylphenidate treatment in adolescent rats with an attention deficit/hyperactivity disorder phenotype: cocaine addiction vulnerability and dopamine transporter function. Neuropsychopharmacology 36:837–847Google Scholar
  24. Hildt E, Lieb K, Bagusat C, Franke AG (2015) Reflections on addiction in students using stimulants for neuroenhancement: a preliminary interview study. BioMed Res Int. Article ID 621075:7.
  25. Humphreys KL, Eng T, Lee SS (2013) Stimulant medication and substance use outcomes: a meta-analysis. JAMA Psychiatry 70(7):740–749. Google Scholar
  26. Hyman SE (2007) How mice cope with stressful social situations. Cell 131:232–234Google Scholar
  27. Izenwasser S, Coy AE, Ladenheim B, Loeloff RJ, Cadet JL, French D (1999) Chronic methylphenidate alters locomotor activity and dopamine transporters differently from cocaine. Eur J Pharmacol 373:187–193Google Scholar
  28. Jones Z, Dafny N (2013) Dose response effect of methylphenidate on ventral tegmental area neurons and animal behavior. Brain Res Bull 96:86–92Google Scholar
  29. Jones Z, Dafny N (2014) Acute and chronic dose-response effect of methylphenidate on ventral tegmental area neurons correlated with animal behavior. J Neural Transm 121(3):327–345. Google Scholar
  30. Juarez B, Han MH (2016) Diversity of dopaminergic neural circuits in response to drug exposure. Neuropsychopharmacology 41(10):2424–2446Google Scholar
  31. Kafetzopoulos E (1986) Effects of amphetamine and apomorphine on locomotor activity after kainic acid lesion of the nucleus accumbens septi in the rat. Psychopharmacology 88:271–274Google Scholar
  32. Kalivas P (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Rev 18(1):75–113Google Scholar
  33. Kalivas PW, Duffy P (1993) Time course of extracellular dopamine and behavioral sensitization to cocaine, II. Dopamine perikaryal. J Neurosci 13:276–284Google Scholar
  34. Kalivas PW, Stewart J (1991) Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev 16(3):223–244Google Scholar
  35. Kalivas PW, Weber B (1988) Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J Pharmacol Exp Ther 245:1095–1102Google Scholar
  36. Kallman WM, Isaac W (1975) The effects of age and illumination on the dose-response curves for three stimulants. Psychopharmacologia 40:313–318Google Scholar
  37. Karreman and Moghaddam (1996) The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area. J Neurochem 66(2):589–598Google Scholar
  38. Kelly PH, Roberts DC (1983) Effects of amphetamine and apomorphine on locomotor activity after 6-OHDA and electrolytic lesions of the nucleus accumbens septi. Pharmacology Biochem Behav 19:137–143Google Scholar
  39. Kelly PH, Seviour PW, Iversen SD (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus and corpus striatum. Brain Res 94:507–522Google Scholar
  40. Kelsey JE, Willmore EJ (2006) Electrolytic lesions of the nucleus accumbens enhance locomotor sensitization to nicotine in rats. Behav Neuroscie 120:600–611Google Scholar
  41. Kita H, Kitai ST (1987) Efferent projections of the subthalamic nucleus in the rat: light and electron microscopic analysis with the PHA-L method. J Comp Neurol 260(3):435–452Google Scholar
  42. Konieczny J, Czarnecka A, Lenda T, Kaminska K, Antkiewicz-Michaluk L (2017) The significance of rotational behavior and sensitivity of striatal dopamine receptors in hemiparkinsonian rats: a comparative study of lactacystin and 6-OHDA. Neuroscience 340:308–318Google Scholar
  43. Koob GF, Stinus L, Le Moal M (1981) Hyperactivity and hypoactivity produced by lesions to the mesolimbic dopamine system. Behav Brain Res 3(3):341–359Google Scholar
  44. Lavoie B, Parent A (1994) Pedunculopontine nucleus in the squirrel monkey: distribution of cholinergic and monoaminergic neurons in the mesopontine tegmentum with evidence for the presence of glutamate in cholinergic neurons. J Comp Neurol 344(2):190–209Google Scholar
  45. Lee MJ, Swann AC, Dafny N (2008) Methylphenidate sensitization is prevented by prefrontal cortex lesion. Brain Res Bull 76:131–140Google Scholar
  46. Lee MJ, Yang PB, Wilcox VT, Burau KD, Swann AC, Dafny N (2009) Does repetitive Ritalin injection produce long-term effects on SD female adolescent rats? Neuropharmacology 57:201–207Google Scholar
  47. Lodge DJ, Grace AA (2006) The laterodorsal tegmentum is essential for burst firing of ventral tegmental area dopamine neurons. Proc Natl Acad Sci USA 103(13):5167–5172Google Scholar
  48. Malenka RC, Nestler EJ, Hyman SE (2009) “Chapter 6: Widely Projecting Systems: Monoamines, Acetylcholine, and Orexin”. In: Sydor A, Brown RY (eds) Molecular neuropharmacology: a foundation for clinical neuroscience, pp 147–148, 2nd edn. McGraw-Hill Medical, New York, pp 154–157Google Scholar
  49. Mannuzza S, Klein RG, Truong NL, Moulton JL 3rd, Roizen ER, Howell KH, Castellanos FX (2008) Age of methylphenidate treatment initiation in children with ADHD and later substance abuse: a prospective follow-up into adulthood. Am J Psychiatry 165(5):604–609Google Scholar
  50. Morello F, Partanen J (2015) Diversity and development of local inhibitory and excitatory neurons associated with dopaminergic nuclei. FEBS Lett 589:3693–3701Google Scholar
  51. Morikawa H, Paladini CA (2011) Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanism. Neuroscience 198:95–111Google Scholar
  52. Nair-Roberts RG, Chatelain-Badie SD, Benson E, White-Cooper H, Bolam JP, Ungless MA (2008) Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat. Neuroscience 152:1024–1031Google Scholar
  53. Nechifor M (2008) Magnesium in drug dependences. Magnes Res 21(1):5–15Google Scholar
  54. Nestler EJ (2001) Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2(2):119–128Google Scholar
  55. Nieh EH, Weele V, Matthews CM, Presbrey GA, Wichmann KN, Leppla R, Izadmehr CA, EM, … Tye, K. M (2016) Inhibitory input from the lateral hypothalamus to the ventral tegmental area disinhibits dopamine neurons and promotes behavioral activation. Neuron 90(6):1286–1298Google Scholar
  56. Olson VG, Nestler EJ (2007) Topographical organization of GABAergic neurons within the ventral tegmental area of the rat. Synapse 61:87–95Google Scholar
  57. Patrick KS, Markowitz JS (1997) Pharmacology of methylphenidate, amphetamine enantiomers and pemoline in attention-deficit hyperactivity disorder. Human Psychopharmacol Clin Exp 12:246–527Google Scholar
  58. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, OrlandoGoogle Scholar
  59. Pert A (1998) Neurobiological substrates underlying conditioned effects of cocaine. Adv Pharmacol 42:991–995Google Scholar
  60. Perugini M, Vezina P (1994) Amphetamine administered to the ventral tegmental area sensitized rats to the locomotor effects of nucleus accumbens amphetamine. J Pharmacol Exp Ther 270:690–696Google Scholar
  61. Pierce RC, Kalivas PW (1997) A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res Rev 25(2):192–216Google Scholar
  62. Prieto-Gomez B, Vazquez-Alvarez AM, Martinez-Pena JL, Reyes-Vazquez C, Yang PB, Dafny N (2005) Methylphenidate and amphetamine modulate differently the NMDA and AMPA glutamatergic transmission of dopaminergic neurons in the ventral tegmental area. Life Sci 77(6):635–649Google Scholar
  63. Purves D, Augustine GJ, Fitzpatrick D et al (eds) (2001) Neural Centers Responsible for Movement. Neuroscience, 2nd edn. Sinauer Associates, Sunderland (MA)Google Scholar
  64. Ranaldi R, Wise RA (2001) Blockade of D1 dopamine receptors in the ventral tegmental area decreases cocaine reward: possible role for dendritically released dopamine. J Neurosci 21:5841–5846Google Scholar
  65. Roberts DC, Koob GF (1982) Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacol Biochem Behav 17(5):901–904Google Scholar
  66. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitation theory of addiction. Brain Res Brain Res Rev 18:247–291Google Scholar
  67. Rui G, Guangjian Z, Yong W, Jie F, Yanchao C, Xi J, Fen L (2013) High frequency electro-acupuncture enhances striatum DAT and D1 receptor expression, but decreases D2 receptor level in 6-OHDA lesioned rats. Behav Brain Res 237:263–269Google Scholar
  68. Shimura T, Kamada Y, Yamamoto T (2002) Ventral tegmental lesions reduce overconsumption of normally preferred taste fluid in rats. Behav Brain Res 134(1–2):123–130Google Scholar
  69. Sotres-Bayon F, Torres-Lopez E, Lopez-Avila A, del Angel R, Pellicer F (2001) Lesion and electrical stimulation of the ventral tegmental area modify persistent nociceptive behavior in the rat. Brain Res 898(2):342–349Google Scholar
  70. Swanson JM, Cantwell D, Lerner M, McBurnett K, Hanna G (1991) Effects of stimulant medication on learning in children with ADHD. J Learn Disab 24:219–230, 255Google Scholar
  71. Tritsch NX, Ding JB, Sabatini BL (2012) Dopaminergic neurons inhibit striatal output through non-canonical release of GABA. Nature 490(7419):262–266Google Scholar
  72. Vezina P (1993) Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat. Brain Res 605:332–337Google Scholar
  73. Volkow ND, Wang GJ, Tomasi D, Kollins SH, Wigal TL, Newcorn JH, Teland FW, Fowler JS, Logan J, Wong CT, Swanson JM (2012) Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. J Neurosci 32(3):841–849Google Scholar
  74. Wanchoo SJ, Lee MJ, Swann AC, Dafny N (2010) Bilateral six-hydroxydopamine administration to PFC prevents the expression of behavioral sensitization to methylphenidate. Brain Res 1312:89–100Google Scholar
  75. Wilens TE, Faraone SV, Biederman J, Gunawardene S (2003) Does stimulant therapy of Attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111:179–118Google Scholar
  76. Yang PB, Amini B, Swann A, Dafny N (2003) Strain differences in the behavioral responses of male rats to chronic methylphenidate. Brain Res 971:139–152Google Scholar
  77. Yang PB, Swann AC, Dafny N (2006) Chronic methylphenidate modules locomotor activity and sensory evoked responses in the VTA and NAc of freely behaving rats. Neuropharmacology 51:546–556Google Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Neurobiology and AnatomyUniversity of Texas Health Science Center at Houston, McGovern Medical SchoolHoustonUSA

Personalised recommendations